Drugs / Yibiao
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT07314424 | Jan 2026 → Oct 2027 expected | anemia | Tang Xiaodong | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Yibiao | “Yibiao 150IU/kg subcutaneous injection” NCT07314424 ↗ |
| Route | Subcutaneous | “Yibiao 150IU/kg subcutaneous injection” NCT07314424 ↗ |